X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1075) 1075
animals (1041) 1041
male (845) 845
neprilysin - antagonists & inhibitors (828) 828
neprilysin (732) 732
rats (487) 487
heart failure (478) 478
neprilysin - metabolism (472) 472
cardiac & cardiovascular systems (435) 435
neutral endopeptidase (432) 432
female (395) 395
pharmacology & pharmacy (383) 383
heart failure - drug therapy (273) 273
mice (268) 268
neprilysin inhibition (241) 241
middle aged (238) 238
peptides (225) 225
angiotensin (215) 215
angiotensin-converting enzyme (215) 215
hypertension (214) 214
enzymes (212) 212
biochemistry & molecular biology (210) 210
blood pressure - drug effects (209) 209
protease inhibitors - pharmacology (209) 209
heart-failure (207) 207
enalapril (204) 204
inhibition (197) 197
angiotensin-converting enzyme inhibitors - pharmacology (195) 195
natriuretic peptides (184) 184
heart failure - physiopathology (181) 181
peripheral vascular disease (175) 175
aged (174) 174
mortality (171) 171
adult (169) 169
neurosciences (166) 166
tetrazoles - therapeutic use (157) 157
neprilysin - genetics (156) 156
alzheimer's disease (154) 154
expression (154) 154
aminobutyrates - therapeutic use (150) 150
lcz696 (149) 149
angiotensin receptor antagonists - therapeutic use (147) 147
blood-pressure (143) 143
dose-response relationship, drug (135) 135
valsartan (134) 134
glycopeptides - pharmacology (133) 133
enkephalinase (130) 130
angiotensin-converting enzyme inhibitors - therapeutic use (129) 129
physiology (126) 126
rats, sprague-dawley (126) 126
heart diseases (123) 123
cell biology (122) 122
treatment outcome (122) 122
atrial-natriuretic-peptide (121) 121
rats, wistar (119) 119
analysis (118) 118
metabolism (118) 118
research (118) 118
brain (116) 116
hypertension - drug therapy (115) 115
disease models, animal (114) 114
atrial natriuretic factor - blood (112) 112
abridged index medicus (111) 111
double-blind (110) 110
substance-p (110) 110
thiorphan - pharmacology (109) 109
peptide (108) 108
peptidyl-dipeptidase a - metabolism (108) 108
proteins (108) 108
sacubitril/valsartan (108) 108
blood pressure (107) 107
bradykinin (107) 107
neprilysin - physiology (106) 106
receptor (100) 100
time factors (100) 100
in vitro techniques (99) 99
medicine, research & experimental (98) 98
amyloid beta-peptides - metabolism (96) 96
double-blind method (96) 96
ejection fraction (96) 96
heart (95) 95
kidney - drug effects (95) 95
alzheimers-disease (94) 94
degradation (94) 94
gene expression (94) 94
physiological aspects (94) 94
atrial natriuretic peptide (93) 93
hydrolysis (91) 91
omapatrilat (90) 90
enzyme inhibitors - pharmacology (89) 89
kinetics (89) 89
patients (88) 88
rodents (88) 88
amino acid sequence (87) 87
cardiology (87) 87
medicine, general & internal (86) 86
preserved ejection fraction (85) 85
a-beta (84) 84
renin-angiotensin system - drug effects (84) 84
biomarkers (83) 83
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2242) 2242
German (21) 21
Japanese (15) 15
Russian (7) 7
French (5) 5
Portuguese (5) 5
Spanish (3) 3
Chinese (2) 2
Italian (2) 2
Norwegian (2) 2
Polish (2) 2
Czech (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 11, pp. 993 - 1004
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 6, pp. 539 - 548
Journal Article
European journal of heart failure, ISSN 1388-9842, 2013, Volume 15, Issue 9, pp. 1062 - 1073
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 17, pp. 1609 - 1620
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1062 - 1064
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2016, Volume 133, Issue 11, pp. 1115 - 1124
Heart failure affects ≈5.7 million people in the United States alone. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, β-blockers, and... 
Heart failure | Prescription drugs | Pharmacology | Natriuretic peptides | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | ATRIAL-NATRIURETIC-PEPTIDE | HEART-FAILURE | PHARMACODYNAMICS | TRIAL | natriuretic peptides | GROWTH-FACTOR-BETA | PHARMACOKINETICS | prescription drugs | pharmacology | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | LCZ696 | CONVERTING-ENZYME INHIBITOR | ENDOPEPTIDASE INHIBITION | Drug Costs | Prodrugs - administration & dosage | Valsartan - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Tetrazoles - economics | Angiotensin Receptor Antagonists - pharmacology | Heart Failure - physiopathology | Hypertension - drug therapy | Thiazepines - adverse effects | Thiazepines - therapeutic use | Aminobutyrates - therapeutic use | Biphenyl Compounds - metabolism | Biphenyl Compounds - therapeutic use | Enalapril - therapeutic use | Contraindications | Pyridines - adverse effects | Aminobutyrates - pharmacokinetics | Multicenter Studies as Topic | Valsartan - therapeutic use | Tetrazoles - administration & dosage | Female | Aminobutyrates - administration & dosage | Pyridines - therapeutic use | Bradykinin - metabolism | Kidney - drug effects | Enzyme Inhibitors - metabolism | Valsartan - pharmacokinetics | Stroke Volume - drug effects | Aminobutyrates - metabolism | Enzyme Inhibitors - therapeutic use | Heart Failure - drug therapy | Randomized Controlled Trials as Topic | Drug Synergism | Pregnancy | Natriuretic Peptides - physiology | Prodrugs - pharmacokinetics | Abnormalities, Drug-Induced - etiology | Neprilysin - antagonists & inhibitors | Aminobutyrates - economics | Hyperkalemia - chemically induced | Angioedema - chemically induced | Tetrazoles - therapeutic use | Prodrugs - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Tetrazoles - pharmacokinetics | Care and treatment | Dosage and administration | Analysis | Angiotensin II receptor blockers | natriuretic peptide | drug
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2019, Volume 380, Issue 11, pp. 1090 - 1090
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure (N Engl J Med 2019;380:539-548). The footnotes were omitted from Table 1... 
MEDICINE, GENERAL & INTERNAL | Heart failure | Neprilysin | Health risk assessment | Heart diseases | Angiotensin
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 17, pp. 2139 - 2153
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 24, pp. 2335 - 2337
.... The drug had an acceptable safety profile over a median follow-up of 27 months. However, some potential long-term side effects connected with the inhibition of neprilysin warrant consideration... 
MEDICINE, GENERAL & INTERNAL | CANCER | Humans | Neprilysin - antagonists & inhibitors | Female | Male | Tetrazoles - therapeutic use | Aminobutyrates - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Enalapril - therapeutic use | Heart Failure - drug therapy | Heart failure | Enzymes | Medical prognosis | Angiotensin | Neprilysin | Alzheimers disease | Heart diseases | Morbidity | Cancer
Journal Article